Cell Free Energy Inc. is addressing the key challenge that holds back cell-free bioproduction - cost-effective energy source.
Nucleotide triphosphates, the building blocks for mRNA therapeutics, are also energy currency of metabolism.
We develop the source of this currency at cost that will power a quantum leap in biotechnology.
Site-specific, high-efficiency phosphorylation
Minimal waste and byproducts compared to chemical and fermentation processes
Nature evolved enzymes for efficiency in cells - AI and cell-free evolution take them to the next level
Nucleotide triphosphates for mRNA, CFPS, and synthetic biology
Lower-cost mRNA therapeutics production
Reduced dependency on overseas suppliers
Domestic supply chain supporting innovation
Fewer byproducts through enzymatic processes
CEO
Built ML-guided enzyme discovery & prioritization pipeline for a DARPA project. Co-inventor on 30+ IP filings.
CSO
Built experimental bio-data pipeline for ML/AI at Google X. World-class enzymologist, Stanford PostDoc.
Advisor
Scientific & commercial biotech experience in the R&D and manufacturing enzymes for pharma, mRNA therapies. Formerly Dir of BD for pharma enzymes at Ginkgo Bioworks.
Advisor
Scientific operations for product development & commercialization at Evozyne, Zymergen, Arkea Bio. Formerly CSO & co-founder of Zymergen.
Interested in learning more about Cell Free Energy?